Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$588M |
| 2 |
UnitedHealth
UNH
|
+$429M |
| 3 |
Johnson & Johnson
JNJ
|
+$333M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXE
Expand Energy Corp
EXE
|
+$322M |
| 2 |
JPMorgan Chase
JPM
|
+$304M |
| 3 |
K
Kellanova
K
|
+$164M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$156M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Financials | 18.7% |
| 3 | Industrials | 12.07% |
| 4 | Healthcare | 10.44% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
CareCloud
CCLD
$104M
| $21K | ﹤0.01% |
15,096
| – | – |
|
3302
Cocrystal Pharma
COCP
$11.3M
| $20.7K | ﹤0.01% |
14,596
-419
| -3% | -$782 |
|
|
BSIN
3303
Big Sky Industrial
BSIN
$59.6M
| $20.7K | ﹤0.01% |
+17,260
| New | +$32.7K |
|
3304
Immuneering
IMRX
$267M
| $20.4K | ﹤0.01% |
13,366
| – | – |
|
3305
Marker Therapeutics
MRKR
$18.8M
| $19.6K | ﹤0.01% |
15,900
| – | – |
|
3306
Vince Holding Corp
VNCE
$81.3M
| $19.3K | ﹤0.01% |
+10,049
| New | +$29.5K |
|
|
VIGL
3307
DELISTED
Vigil Neuroscience
VIGL
| $19.1K | ﹤0.01% |
+10,704
| New | +$24K |
|
3308
Lineage Cell Therapeutics
LCTX
$269M
| $18.3K | ﹤0.01% |
40,449
| – | – |
|
|
GORV
3309
DELISTED
Lazydays
GORV
| $16.5K | ﹤0.01% |
1,685
-142
| -8% | -$3.06K |
|
3310
IRIDEX
IRIX
$14.3M
| $14.4K | ﹤0.01% |
14,549
-9,889
| -40% | -$14K |
|
3311
Ring Energy
REI
$315M
| $13.1K | ﹤0.01% |
11,409
| – | – |
|
|
RPTX
3312
DELISTED
Repare Therapeutics
RPTX
| $13.1K | ﹤0.01% |
13,265
| – | – |
|
3313
Century Therapeutics
IPSC
$364M
| $12.8K | ﹤0.01% |
26,735
-139
| -0.5% | -$104 |
|
|
UBX
3314
DELISTED
Unity Biotechnology
UBX
| $11.6K | ﹤0.01% |
+11,120
| New | +$20.1K |
|
3315
PEDEVCO
PED
$144M
| $8.89K | ﹤0.01% |
635
| – | – |
|
|
IAUX
3316
i-80 Gold Corp
IAUX
$1.11B
| $8.67K | ﹤0.01% |
+14,900
| New | +$9.64K |
|
3317
Village Farms International
VFF
$234M
| $7.49K | ﹤0.01% |
12,380
| – | – |
|
3318
Lyell Immunopharma
LYEL
$317M
| $7.24K | ﹤0.01% |
673
| – | – |
|
3319
NextCure
NXTC
$16.8M
| $5.85K | ﹤0.01% |
1,015
-6,139
| -86% | -$54.2K |
|
3320
Ovid Therapeutics
OVID
$414M
| $3.34K | ﹤0.01% |
10,719
-82,252
| -88% | -$50.6K |
|
|
AFMD
3321
DELISTED
Affimed
AFMD
| – | – |
-18,120
| Closed | -$21.6K |
|
|
ALLK
3322
DELISTED
Allakos
ALLK
| – | – |
-89,998
| Closed | -$109K |
|
3323
ALX Oncology
ALXO
$261M
| – | – |
-26,233
| Closed | -$43.8K |
|
3324
Sphere 3D
ANY
$18.5M
| – | – |
-3,164
| Closed | -$29.9K |
|
3325
Array Technologies
ARRY
$803M
| – | – |
-525,240
| Closed | -$3.17M |
|
Similar funds
Dimensional Fund Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Dimensional Fund Advisors held 3,398 positions worth $402B, down 3.4% from $416B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4%. Dimensional Fund Advisors opened 59 new positions and exited 78, leaving the 3,398-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2025 buy was Sandisk: 849,963 shares worth $40.5M.
- Dimensional Fund Advisors added most to Apple in Q1 2025, an estimated $588M increase.
- Dimensional Fund Advisors's biggest Q1 2025 reduction was Expand Energy Corp, cutting an estimated $322M.
- Dimensional Fund Advisors fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $159M.
- Dimensional Fund Advisors's ten largest holdings make up 15% of its $402B portfolio in Q1 2025.
- Dimensional Fund Advisors opened 59 new positions and closed 78 in Q1 2025.
- Dimensional Fund Advisors's portfolio value fell 3.4% quarter-over-quarter to $402B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2025, filed 13 May 2025.